Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of XIAFLEX® ...

The global clinical trials market has emerged as a vital cornerstone of the healthcare sector, driven by an ever-increasing ...

Bipolar disorder is a severe mental illness characterised by episodes of mania (high energy, impulsivity) and depression ...

Superconductivity Limitations Electricity has been one of the most transformative technologies in history, allowing for the transmission of a very useful form of energy over long distances. But every ...

Halo Pharmaceutical is a privately owned full service FDA, BLA and DEA (Schedule II-V) compliant CDMO, headquartered in ...

CMS issued its Final Rule, establishing new Clinical Laboratory Improvement Amendments (CLIA) regulations (the Final ...

Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature ...

Embarking on a medical career is an exciting yet demanding journey. Medical education involves mastering complex scientific ...

The Phase 1 trial of the second-generation triterpenoid antifungal SCY-247, initiated in December of 2024, continues and results are expected in ...

Recent cuts to the federal workforce could negatively impact cancer research and public health for years to come, researchers say.

Indoco’s clinical research organisation, AnaCipher completes US FDA inspection: Our Bureau, Mumbai Tuesday, March 11, 2025, 11:30 Hrs [IST] Indoco Remedies Limited (Indoco), a f ...

Indoco Remedies declined 3.22% to Rs 224.20 after its Clinical Research Organization, AnaCipher, located in Hyderabad, received one Form 483 from the United States Food and Drug Administration (US FDA ...